伟思医疗
(688580)
| 流通市值：38.02亿 | | | 总市值：38.02亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 324,932,138.88 | 226,437,246.19 | 106,040,321.83 | 462,725,664.61 |
| 营业收入 | 324,932,138.88 | 226,437,246.19 | 106,040,321.83 | 462,725,664.61 |
| 二、营业总成本 | 237,185,927.38 | 158,213,887.06 | 74,643,980.57 | 344,480,453.6 |
| 营业成本 | 111,239,211.56 | 76,288,886.97 | 35,887,302.77 | 156,456,654.82 |
| 税金及附加 | 4,253,199.04 | 2,899,958.22 | 2,485,544.9 | 6,598,119.49 |
| 销售费用 | 59,013,736.5 | 37,741,541.92 | 15,697,981.25 | 91,800,951.92 |
| 管理费用 | 32,819,805.74 | 21,266,657.98 | 10,809,627.29 | 47,361,513.36 |
| 研发费用 | 32,755,878 | 21,995,513.42 | 10,780,108.67 | 45,116,123.69 |
| 财务费用 | -2,895,903.46 | -1,978,671.45 | -1,016,584.31 | -2,852,909.68 |
| 其中:利息费用 | 10,240.43 | 7,626.44 | 4,836.13 | 1,308,051.09 |
| 其中:利息收入 | 3,108,138.25 | 2,107,405.02 | 1,070,574.96 | 4,212,882.79 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 4,835,413.96 |
| 加:投资收益 | 8,939,225.63 | 5,834,397.97 | 2,550,983.42 | 12,533,301.1 |
| 资产处置收益 | 33,172,398.75 | 33,201,910.35 | 32,136,104.12 | -880.57 |
| 资产减值损失(新) | -19,875.35 | -64,656.8 | - | -430,627.75 |
| 信用减值损失(新) | -175,945.48 | -182,093.98 | 99,626.15 | -835,770.56 |
| 其他收益 | 11,286,557.18 | 7,656,495.34 | 4,182,167.54 | 17,976,980.19 |
| 四、营业利润 | 140,948,572.23 | 114,669,412.01 | 70,365,222.49 | 152,323,627.38 |
| 加:营业外收入 | 73,161.61 | 29,748.79 | 2,213.26 | 2,197,890.44 |
| 减:营业外支出 | 429,597.4 | 383,410.33 | 2,213.94 | 89,857.11 |
| 五、利润总额 | 140,592,136.44 | 114,315,750.47 | 70,365,221.81 | 154,431,660.71 |
| 减:所得税费用 | 16,624,189.12 | 14,193,030.54 | 8,791,905.02 | 16,359,015.21 |
| 六、净利润 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| 扣除非经常损益后的净利润 | 88,280,677.89 | 67,043,515.85 | 33,065,027.7 | 121,384,115.98 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.3 | 1.05 | 0.64 | 1.44 |
| (二)稀释每股收益 | 1.3 | 1.05 | 0.64 | 1.44 |
| 九、综合收益总额 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| 归属于母公司股东的综合收益总额 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| 公告日期 | 2026-10-27 | 2026-08-26 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |